Emerging areas for more study include dietary modulation of endogenous GLP‐1, strategies to improve compliance, nutritional priorities for weight maintenance post‐cessation, combination or staged intensive lifestyle management, and diagnostic criteria for clinical obesity. The gene discussed is GCG; the disease is obesity disorder.